Study
Natural Supplement May Reduce Oxidative Stress in IBD Patients
Taking a Pistacia lentiscus supplement improved oxidative stress markers and quality of life in patients with inflammatory bowel disease.
Summary
In plain language
A recent study explored the effects of a natural supplement made from Pistacia lentiscus, a plant known for its health benefits, on patients with inflammatory bowel disease (IBD). Researchers found that the supplement helped reduce oxidative stress, a harmful condition linked to inflammation, and improved the quality of life for those with active IBD. The study suggests that adding this supplement to regular medical treatment might be beneficial for managing IBD symptoms. This could be an important consideration for seniors dealing with IBD, as it offers a potential natural way to support their health.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was conducted as a randomized, double-blind trial with 60 patients who have IBD. Participants took either a Pistacia lentiscus supplement or a placebo for three months while continuing their usual medical treatments.
The supplement group showed a reduction in oxidative stress markers, indicating less damage from inflammation.
Participants also reported an improvement in their overall quality of life during the study period.
While the results are promising, further research is needed to confirm these findings and understand the long-term effects.
Seniors interested in this supplement should discuss it with their healthcare providers to ensure it fits their treatment plan.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Natural Supplement May Reduce Oxidative Stress in IBD Patients
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 26, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scores highly due to its rigorous randomized controlled trial design, comprehensive bias control measures, and transparent reporting. However, the absence of journal information and external replication, along with limited relevance to the target population, reduce the overall score. The conflicts score is affected by the industry-related funding source despite clear COI disclosure.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study investigates the effects of a Pistacia lentiscus supplement on oxidative stress biomarkers in IBD patients. It is a randomized, double-blind, placebo-controlled trial showing potential antioxidant benefits, particularly in Crohn's disease patients.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.